Michael Peluso, Md
Clinical trials sponsored by Michael Peluso, Md, explained in plain language.
-
HIV breakthrough? drug may let patients ditch daily meds
Disease control ENROLLING_BY_INVITATIONThis study tests whether a drug called N-803 (IL-15) can train the immune system to control HIV without daily antiretroviral therapy. Twenty people with HIV on stable treatment will receive the drug or a placebo, then temporarily stop their HIV meds to see if the virus stays unde…
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could an antibody finally treat long COVID?
Disease control OngoingThis study tests whether a single dose of the monoclonal antibody AER002 can safely improve physical health in adults with Long COVID. The idea is that lingering virus or spike protein may cause ongoing symptoms, and the antibody might clear it. 36 participants will receive eithe…
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC